Company intelligence / Profile preview

Spring Street Capital

New York City, New York, United Statesspringstcap.com ↗

Ownership: Private
Development stage: Commercial

Overview

Spring Street Capital is a private investment firm founded in 2024 and based in New York City. The company focuses on buyouts and scaling of enduring software businesses, with no evidence of activity or specialization in life sciences, biotech, pharma, or healthcare sectors[1][2][3].

Industry: Investors

Partnerships

None known (no major pharmaceutical or biotech partnerships identified)

Beyond the preview

Go deeper on Spring Street Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spring Street Capital.

Explore the full profile